NEDD9 and melanoma: In the process of identification of the genomic events associated with the acquisition of metastatic potential, Kim et al., reported amplification of NEDD9. NEED9 is more frequently overexpressed in metastatic melanoma than in primary melanoma and overexpression is correlated with melanoma progression.